The Technical Analyst
Select Language :
MyMD Pharmaceuticals, [MYMD]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

MyMD Pharmaceuticals, Price, Forecast, Insider, Ratings, Fundamentals & Signals

MyMD Pharmaceuticals, is listed at the  Exchange

-1.70% $2.31

America/New_York / 28 mar 2024 @ 15:34


MyMD Pharmaceuticals,: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 4.83 mill
EPS: -5.10
P/E: -0.450
Earnings Date: Mar 29, 2024
SharesOutstanding: 2.09 mill
Avg Daily Volume: 0.0515 mill
RATING 2024-03-28
A+
Strong Buy
RATINGS
Rating CashFlow: Neutral
Return On Equity: Strong Buy
Return On Asset: Strong Buy
DE: Sell
P/E: Strong Buy
Price To Book: Strong Buy
QUARTER GROWTHS
2/223/224/221/232/233/23
Revenuen/an/an/an/an/an/a
Gr.Profitn/an/an/an/an/an/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -0.450 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.08x
Company: PE -0.450 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$0.0156
(-99.32%) $-2.29
Date: 2024-03-28
Expected Trading Range (DAY)

$ 2.01 - 2.73

( +/- 15.11%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2023-08-24 Rivard Paul Buy 150 000 Common stock
2023-08-17 Rivard Paul Buy 25 000 Common stock
2023-06-07 Chapman Christopher C Jr Buy 300 000 Employee Stock Option (Right to Buy)
2023-06-07 Kaplin Adam Buy 150 000 Employee Stock Option (Right to Buy)
2023-06-07 Uzonwanne Jude Buy 150 000 Employee Stock Option (Right to Buy)
INSIDER POWER
100.00
Last 84 transactions
Buy: 8 636 568 | Sell: 532 775

Forecast: 16:00 - $2.31

Live Trading Signals (every 1 min)

Forecast 1: 15:43 - $2.35
Forecast 2: 16:00 - $2.31
Forecast 3: 16:00 - $2.31
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $2.31 (-1.70% )
Volume 0.0304 mill
Avg. Vol. 0.0515 mill
% of Avg. Vol 58.98 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for MyMD Pharmaceuticals, Inc.

Last 12 Months

Last 12 months chart data with high, low, open and close for MyMD Pharmaceuticals, Inc.

RSI

Intraday RSI14 chart for MyMD Pharmaceuticals, Inc.

Last 10 Buy & Sell Signals For MYMD

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            MyMD Pharmaceuticals, Inc.

MYMD

MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines; and to delay aging and increase longevity, as well as treat autoimmune diseases and COVID-19-associated depression. It is also developing Supera-CBD, a synthetic derivative of cannabidiol for treating chronic pain, addiction, and epilepsy. The company was founded in 2014 and is headquartered in Baltimore, Maryland.

Last 10 Buy Signals

Date Signal @
GNSUSDMar 28 - 15:305.10
KRYSMar 28 - 15:32$177.33
ULTAMar 28 - 15:31$523.00
TGTXMar 28 - 15:32$15.31
WTAOUSDMar 28 - 15:28547.49
NBIXMar 28 - 15:30$137.23
PHBUSDMar 28 - 15:252.75
PFFMar 28 - 15:25$32.34
CRSPMar 28 - 15:23$68.01
CVCUSDMar 28 - 15:23$0.217

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.